Bharat Biotech announces data from phase-III Covaxin clinical trials
Covaxin was well-tolerated and the Data Safety Monitoring Board has not reported any safety concerns related to the vaccine, the…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.